DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Clovis Oncology, Inc. (CLVS)
« Back to company indexCLVS Chatter Timeline
Stock Ticker for CLVS
Most Active Tweeters for CLVS
| User | Tweets |
|---|---|
| @bulletin_en | 13 |
| @AmericanBanking | 9 |
| @reurope_stock | 9 |
| @mmahotstuff1 | 9 |
| @1MinuteStock | 8 |
Recent Tweets for CLVS
 |
@Sanctuary_Bio @BayAreaBiotechI That $CLVS one is something else The only 'hype' left with the company is if Mahaffy will success… https://t.co/jRl71jT8gw April 19th 2019, 1:04pm |
 |
@BioAnalysisCent $CLVS Biotech Analysis Central "Clovis Oncology Suffers Setback, But Additional Options Remain" https://t.co/nS8jK3AhHm April 19th 2019, 1:04pm |
 |
@TickerReport Clovis Oncology $CLVS Cut to Sell at Zacks Investment Research https://t.co/1BHPPrUHfP April 19th 2019, 4:04am |
 |
@dailypoliticaln Clovis Oncology $CLVS Rating Lowered to Sell at Zacks Investment Research https://t.co/ylYaPopXey April 19th 2019, 4:04am |
 |
@ConsumerFeed Clovis Oncology $CLVS PT Lowered to $37.00 at HC Wainwright https://t.co/MckoVR3aPX April 19th 2019, 3:04am |
 |
@TranscriptDaily SunTrust Banks Comments on Clovis Oncology’s FY2019 Earnings $CLVS https://t.co/glGMFRb9ff April 19th 2019, 3:04am |
 |
@stocknewstimes SunTrust Banks Comments on Clovis Oncology’s FY2019 Earnings $CLVS https://t.co/AwSgoLXxLN April 19th 2019, 3:04am |
 |
@ThisLincolnian Piper Jaffray Companies Analysts Lower Earnings Estimates for Clovis Oncology $CLVS https://t.co/0ebalbULSf April 19th 2019, 1:04am |
 |
@sunrgu @SeekingAlpha $CLVS by the way they stopped open label P2 study not P3 April 18th 2019, 9:04pm |
 |
@bibeypost_stock Were Analysts Bullish Clovis Oncology, Inc. $CLVS This Week? https://t.co/INj1mDBDmM April 18th 2019, 4:04pm |
 |
@Rajt1111 Almost 6% move, $CLVS. Let’s see what next few week hold for it. I am expecting slow grind to upper 20’s prior to earnings release. April 18th 2019, 4:04pm |
 |
@thefinreviewer Armistice Capital Raised Clovis Oncology $CLVS Position; Amp Capital Investors LTD Upped Public Storage $PSA Holdin… https://t.co/KRkviSgfrO April 18th 2019, 3:04pm |
 |
@NewsQuantified $CLVS Suffers Setback, But Additional Options Remain, stock rises +1.30%, #ClovisOncology https://t.co/UJ9ZHKdVI2 April 18th 2019, 1:04pm |
 |
@SeekingAlpha $CLVS - Clovis Oncology Suffers Setback, But Additional Options Remain https://t.co/4sr6ibXMk3 April 18th 2019, 11:04am |
 |
@AmericanBanking Clovis Oncology $CLVS Receives Average Recommendation of “Hold” from Analysts https://t.co/ZwlsHNdGXl #stocks April 18th 2019, 8:04am |
 |
@registrarjourn Clovis Oncology $CLVS Receives Average Recommendation of “Hold” from Analysts https://t.co/t1fFsAJtKo April 18th 2019, 8:04am |
 |
@EnterpriseLeade Clovis Oncology $CLVS Receives Average Recommendation of “Hold” from Analysts https://t.co/H5RKo6rrfT April 18th 2019, 8:04am |
 |
@dispatchtribune Clovis Oncology $CLVS Receives Consensus Rating of “Hold” from Brokerages https://t.co/IlAXSgo9SB April 18th 2019, 8:04am |
 |
@UlmHi Clovis Oncology $CLVS Gets BidaskScore Lower Rating; DAIMLER AG $DDAIF Shorts Raised By 1.32% https://t.co/BKrhwXUe5v April 18th 2019, 5:04am |
|
@dakotafinancial Zacks Investment Research Downgrades Clovis Oncology $CLVS to Sell https://t.co/VCsDe4lZWk April 18th 2019, 5:04am |
 |
@macondailynews SunTrust Banks Cuts Clovis Oncology $CLVS Price Target to $28.00 https://t.co/Gotrn7tiEZ April 18th 2019, 5:04am |
 |
@TheMarketsDaily Clovis Oncology $CLVS Price Target Lowered to $28.00 at SunTrust Banks https://t.co/wgCmVWO3FV April 18th 2019, 5:04am |
|
@registrarjourn FY2019 Earnings Forecast for Clovis Oncology Issued By SunTrust Banks $CLVS https://t.co/uZw495eJOg April 18th 2019, 2:04am |
|
@EnterpriseLeade FY2019 Earnings Forecast for Clovis Oncology Issued By SunTrust Banks $CLVS https://t.co/7oPxxbQaHK April 18th 2019, 2:04am |
 |
@WeekHerald Clovis Oncology $CLVS Price Target Cut to $21.00 by Analysts at Piper Jaffray Companies https://t.co/ITyE1OsGit April 18th 2019, 2:04am |
 |
@OlympiaReport Clovis Oncology $CLVS Price Target Cut to $21.00 by Analysts at Piper Jaffray Companies https://t.co/ICbyUYzqbZ April 18th 2019, 2:04am |
 |
@WatchlistN Clovis Oncology $CLVS Shares Gap Down on Analyst Downgrade https://t.co/9zzi2RV5go April 18th 2019, 1:04am |
 |
@hilo_SF $CLVS might want to fill the lower gap before turning her head up ? ? ( Using chart program Pro ?… https://t.co/D7icMpF82L April 17th 2019, 10:04pm |
 |
@mmahotstuff1 Clovis Oncology $CLVS Receives a Lower Rating From BidaskScore. Is it Time to Sell Shares? https://t.co/5xqUuq41tr April 17th 2019, 7:04pm |
 |
@whatsonthorold2 Time To Sell Clovis Oncology $CLVS? BidaskScore Downgrades Shares Today https://t.co/S72ucn8hNN April 17th 2019, 7:04pm |
 |
@reurope_stock Will Today’s BidaskScore Downgrade Harm Clovis Oncology $CLVS Stock? https://t.co/NGZyjgAZeg April 17th 2019, 7:04pm |
|
@thefinreviewer Neuralstem Inc. $CLVS Comparison side by side https://t.co/6IlcutmQxn April 17th 2019, 6:04pm |
|
@blackholeporter $CLVS EV is about 1.7B is it cheap? All comes down to revenue projection. But Pat won’t give one. I predict decent growth so I buy. April 17th 2019, 1:04pm |
 |
@bulletin_en Clovis Oncology Inc $CLVS Q4 2018 Sentiment Reported At 0.76 https://t.co/nwy8q31UdB April 17th 2019, 1:04pm |
|
@TheMarketsDaily Clovis Oncology $CLVS Downgraded by Zacks Investment Research to Sell https://t.co/TYzulbY8kN April 17th 2019, 11:04am |
|
@macondailynews Clovis Oncology $CLVS Downgraded by Zacks Investment Research to Sell https://t.co/bGLHA3jrPy April 17th 2019, 11:04am |
|
@AmericanBanking Clovis Oncology Expected to Post FY2019 Earnings of -$6.37 Per Share $CLVS https://t.co/i6Z3lZTPEN #stocks April 17th 2019, 8:04am |
|
@ConsumerFeed Clovis Oncology Expected to Post FY2019 Earnings of -$6.37 Per Share $CLVS https://t.co/0vV4P4yKVB April 17th 2019, 8:04am |
|
@thefinreviewer Comparison of Innovate Biopharmaceuticals Inc. $CLVS https://t.co/UE1UgnRTxZ April 17th 2019, 8:04am |
|
@UlmHi Sector Gamma As Increased Stake in Clovis Oncology $CLVS; As Hyster Yale Matls Handling $HY Stock Price Declined, S… https://t.co/mmQK2es4OH April 17th 2019, 8:04am |
|
@AmericanBanking Equities Analysts Issue Forecasts for Clovis Oncology’s Q1 2019 Earnings $CLVS https://t.co/jh8kzYdXcK #stocks April 17th 2019, 7:04am |
|
@macondailynews Equities Analysts Issue Forecasts for Clovis Oncology’s Q1 2019 Earnings $CLVS https://t.co/NKfa5JO0Iq April 17th 2019, 7:04am |
|
@dakotafinancial Equities Analysts Issue Forecasts for Clovis Oncology’s Q1 2019 Earnings $CLVS https://t.co/YFg4RoRi86 April 17th 2019, 7:04am |
|
@TranscriptDaily Clovis Oncology $CLVS Downgraded to Strong Sell at BidaskClub https://t.co/sX1JUkJCZH April 17th 2019, 5:04am |
|
@dailypoliticaln Piper Jaffray Companies Trims Clovis Oncology $CLVS Target Price to $21.00 https://t.co/I9xTRBN1VG April 17th 2019, 4:04am |
|
@ConsumerFeed Clovis Oncology $CLVS PT Lowered to $28.00 https://t.co/2AXUFg3uh0 April 17th 2019, 4:04am |
|
@TickerReport Piper Jaffray Companies Trims Clovis Oncology $CLVS Target Price to $21.00 https://t.co/H2hVrGcYub April 17th 2019, 4:04am |
|
@macondailynews Clovis Oncology Target of Unusually High Options Trading $CLVS https://t.co/N1frVlH7DK April 17th 2019, 1:04am |
|
@TheMarketsDaily Clovis Oncology Target of Unusually High Options Trading $CLVS https://t.co/XumM9QkdCw April 17th 2019, 1:04am |
 |
@ZolmaxNews Clovis Oncology $CLVS Stock Price Down 12.5% Following Analyst Downgrade https://t.co/84gukmDX0L April 17th 2019, 1:04am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.